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Background: The incidence and treatment strategies of acute coronary syndrome (ACS) vary by region. Addition-
ally, the clinical spectrum of ACS is changing and outcomes are improving.
Aim:We assessed the incidence, treatment strategies, and outcomes of ACS for a well-deﬁned population within
a well-established network of percutaneous coronary intervention (PCI) centers and non-PCI centers.
Methods: The CZECH-2 registry included 1221 consecutive patients (mean age: 68 ± 13 years; 63.4% males) ad-
mitted for suspected ACS to 32 hospitals (including 4 PCI centers) within four Czech counties (total population:
2,370,841 inhabitants) during a 2-month period.
Results: The estimated incidence of conﬁrmed ACS was 2149 cases/million/year. In 374 (31%) patients, ACS was
ruled out during the hospital stay. Coronary angiography (CAG)was performed in 60% of the patients overall and
PCIwas performed in 59% of the conﬁrmed ACS patients. Killip classiﬁcations II–IV on admissionweremore com-
mon in patients with ﬁnal diagnosis of non ST-elevationmyocardial infarction (NSTEMI) than ST-elevationmyo-
cardial infarction (STEMI) (37.1% vs. 22.8%; p b 0.001). The 30-day mortality rate was 5.7% for the whole study
group, 7.3% for STEMI patients, 8.4% for NSTEMI patients, and 1.6% for patients with unstable angina pectoris
(UAP), respectively.
Conclusions: Almost one-third of the patients admitted for suspected ACS had a different ﬁnal diagnosis. Among
those with conﬁrmed ACS, the use of CAG, PCI, CABG, and effective medications is rational. Outcome in NSTEMI
patients was equivalent to those in STEMI patients, mainly due to the high-risk population in this group.© 2014 The Authors. Published by Elsevier Ireland Ltd.Open access under CC BY-NC-ND license. 1. Introduction
During the last 10 to 15 years, the epidemiological situation in the
ﬁeld of acute coronary syndrome (ACS), which varies by country, has
changed [1–9]. The characteristics of patients admitted for ACS is chang-
ing, and the prognosis is improving given the widespread use of
evidence-based pharmacological and interventional treatment strategies
[3,10,11]. In the Czech Republic, there is a well-established network of
tertiary cardiac centers with percutaneous coronary intervention (PCI)of Medicine, Charles University,
63 159; fax:+420 267 162 525.
.
eliability and freedom from bias
land Ltd.Open access under CC BY-NCcapability, as well as non-PCI centers; thus, interventional treatment
for patients admitted to regional hospitals with ACS is easily accessible.
The aim of this registry was to assess the epidemiological data, treat-
ment strategies, and outcomes for unselected patients in a deﬁned popu-
lation who were admitted with an initial diagnosis of ACS to a treatment
center within a well-established PCI network in the Czech Republic.
2. Methods
A total of 28 regional hospitalswithout catheterization availability and 4 cardiocenters
with a catheterization laboratory participated in this prospective observational registry
between 1 October and 30 November 2012. The location of the participating centers with-
in four counties of the Czech Republic is shown in Fig. 1. In the area covered by the registry,
there were 2,370,841 inhabitants according to the Czech Statistical Ofﬁce [12]. The inclu-
sion criteria for entering into the registry were: 1) hospital admission with a diagnosis of
ST segment elevation myocardial infarction (STEMI), non-ST elevation myocardial infarc-
tion (NSTEMI), unstable angina pectoris (UAP), acute heart failure in patients with known-ND license. 
Fig. 1.Map of the Czech Republic with marked 4 counties and the regional hospitals (small asterisks) and cardiocenters (bold asterisks) involved in the registry.
Table 1
Clinical characteristics of the whole study group.
Body mass index, kg/m2 (SD) 29 ± 14
Systolic blood pressure on admission, mm Hg (SD) 145 ± 29
Heart rate on admission, beats/min (SD) 81 ± 21
Ejection fraction during hospitalization, % (SD) 52 ± 13
Troponin elevation during hospitalization 61%
Hypertension 71.1%
Diabetes 34.4%
Insulin therapy 12.5%
Hyperlipidemia 47.6%
Smoking status
Active smokers 26.7%
Ex-smokers 30.3%
History of
MI 24.7%
PCI 20.4%
CABG 9.6%
Stroke 8.4%
Atrial ﬁbrillation 13.3%
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phase, or another initial diagnosis conﬁrmed as ACS during hospitalization, and 2)written
informed consent from the patient with data collection. The registry was approved by a
multicenter ethics committee.
In-hospital or 30-daymortality andmajor adverse cardiovascular events (MACE) (e.g.,
death/reinfarction/stroke/target vessel revascularization) were evaluated in all enrolled
patients. A ﬁnal diagnosis and the conﬁrmation or exclusion of ACS were done according
to the criteria for and deﬁnition of ACS [13,14]. Clinical 30-day follow-up was performed
depending on investigators either by direct telephone call or ofﬁce visit. The estimated in-
cidence of conﬁrmed ACS was based on the number of inhabitants in the area covered by
the registry. Inclusion and exclusion criteria as well as observed cardiovascular events
were predetermined before the start of the registry andwere followed by all investigators.
One responsible investigator in each center controlled the consecutiveness of enrolled pa-
tients admitted for ACS.
2.1. Statistics
Standard descriptive statistics were applied in the analysis, including absolute and
relative frequencies for categorical variables and means supplemented by the standard
deviation for continuous variables. The statistical signiﬁcance of differences among groups
of patients was computed using the maximum likelihood chi-square test for categorical
variables and an analysis of variance (ANOVA) for continuous variables. The level of
statistical signiﬁcance was set at α= 0.05. SPSS 19 for Windows (Release 19.0.1; IBM
Corp., 2010) was used for the analysis.
3. Results
A total of 1221 patientswere enrolled in the registry (730 patients in
regional hospitals and 491 patients in cardiocenters). There were 450
(36.9%) females, with an average age that was higher compared to the
males (71±13 vs. 66± 12 years, p b 0.001). Additional clinical charac-
teristics of the patients are shown in Table 1.
3.1. Diagnosis on admission
The patients were admitted most frequently for chest pain thought
to be due to ACS (440 patients, 36%). A diagnosis of STEMI was made
on admission in 270 (22.1%) patients, 134 (11%) patientswere admitted
with an initial diagnosis of NSTEMI, and 177 (14.5%) patients were ad-
mitted with UAP. Acute heart failure in patients with known coronary
artery disease was the cause of admission in 111 (9.1%) patients, 31
(2.5%) patients were referred to the hospital after cardiopulmonary
resuscitation, and 55 (4.5%) patients were enrolled when ACS wasidentiﬁed after an initial diagnosis that was different from any type of
ACS in the inclusion criteria.3.2. Discharge diagnosis
In 372 (30.5%) patients, ACS was not conﬁrmed during hospital-
ization. The proportions of patients with non-conﬁrmed ACS in
cardiocenters and in regional hospitals were 24% and 34% (p b 0.001).
Table 2 shows differences in clinical characteristics between group of pa-
tients with conﬁrmed ACS and patients in whom ACS was excluded. The
proportion of patients forwhomadifferent type of ACSwas conﬁrmed at
discharge is shown in Fig. 2. Pathological Q waves (Q-MI) developed in
211 (80.8%) of 261 patientswith STEMI and in 80 (19.9%) of 403 patients
with NSTEMI. ACS was also conﬁrmed in 54 of 111 (48.6%) patients ad-
mitted for acute heart failure without chest pain, out of them 36 patients
had ﬁnal diagnosis of NSTEMI, 10 patients STEMI and 8 patients UAP.
Killip classiﬁcations II–IV on admission were more common in patients
with ﬁnal diagnosis of NSTEMI than STEMI (37.1% vs. 22.8%; p b 0.001).
Table 2
Basic clinical characteristics of patients according to conﬁrmation of ACS.
ACS conﬁrmed ACS not conﬁrmed p
Men 67% 54.3% b0.001
Age, years 68 ± 12 67 ± 13 b0.01
Diabetes 35.6% 31.0% 0.191
Hypertension 70.2% 73.1% 0.299
Smoking 30.9% 17.2% b0.001
History of MI 25% 24.8% 0.887
History of PCI 19.9% 21.5% 0.525
History of CABG 10.1% 8.3% 0.321
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Urgent angiography was performed in 246 (94.3%) patients; of
these, 220 (89.4%) subsequently underwent primary PCI while 3
(1.1%) underwent an emergency coronary artery bypass graft (CABG).
Elective CABG was indicated in another 22 (8.4%) patients. The time in-
terval (median) from the onset of chest pain to the ﬁrst diagnostic ECG
was 150min (69–455min for the 25th–75th percentiles). The very ﬁrst
call to the emergency call center was done in 54% of patients, 30.7% vis-
ited hospital by themselves without calling the emergency service,
10.7% was referred by general practitioners and 4.7% by specialists
working out of the hospital. All patientswith diagnosed STEMI indicated
for urgent angiographyhad the direct access to PCI centerwithout being
admitted in regional hospitals or emergency departments. The median
time interval from ECG to catheterization was 85 min (58–128 min for
the 25th–75th percentiles). A conservative approach was taken in 15
patients due to severe polymorbidity (9 patients), malignancy (2 pa-
tients), patient refusal (2 patients), known coronary ﬁndings without
the technical possibility of revascularization (1 patient), and dementia
(1 patient).
3.4. Invasive treatment in patients with ACS without ST elevation
Coronary angiography during hospitalization was performed in 65%
of patients with NSTEMI; of these, 71% of the patients underwent PCI
and 17% underwent a CABG. In the patients with UAP, coronary angiog-
raphy was performed in 66%; this was followed by PCI in 61% of the pa-
tients and by a CABG in 24% of the patients. Differences in the indication
for coronary angiography during hospitalization were observed
between the cardiocenters with PCI capability and regional hospitals
(94 vs. 55% for NSTEMI [p b 0.001] and 98 vs. 52% for UAP [p b 0.001],
respectively). Coronary angiographywas performed up to 72 h after ad-
mission in 59% of NSTEMI patients (31.4% in ﬁrst 24 h) and in 34.5% of
patientswithUAP (10.9% inﬁrst 24 h). In patients admitted to a regional
hospital, coronary angiography was indicated electively after discharge
in another 12% of the patientswithNSTEMI and 25% of the patientswith
UAP. Patients hospitalized at a regional hospital for NSTEMI and UAPFig. 2. Final diagnosis at discharge.were signiﬁcantly older than the patients admitted to a cardiocenter
(average age, 72 ± 12 vs. 68 ± 12 years; p b 0.001).
3.5. Mortality
The in-hospital and 30-daymortality rates in the whole study group
were 4.2 and 5.7%, respectively. The incidence of in-hospital MACE was
4.9% compared to 7.1% for 30-day MACE. The in-hospital and 30-day
outcome of patients according to the discharged diagnosis is shown in
Table 3. In terms of the mortality rate in patients with conﬁrmed myo-
cardial infarction (MI) according to the development of pathological Q
waves on ECG at discharge, the in-hospital mortality rates for nonQ-
IM and Q-IM were 3.8 and 10%, while the 30-day mortality rates were
4.8 and 12%, respectively. The 30-day mortality for patients with Killip
I class on admission was 2.8%, patients presented with Killip II class
had 30-day mortality 10.6%, and patients with Killip III and Killip IV
16.4% and 37.8%, respectively.
3.6. Pharmacologic treatment
On admission, the patients were taking the following medications:
39.8%, aspirin; 7.6%, clopidogrel; 43.2%, beta blockers; 41.6%, ACE
inhibitors; 40.4%, statins; and 8.7%, oral anticoagulants. At discharge,
in patients with conﬁrmed ACS, the followingmedicationswere admin-
istered: aspirin, 93.5%; clopidogrel, 76.4%; prasugrel, 0.6%; ticagrelor,
0.8%; oral anticoagulation 9.5%; beta blockers, 77.5%; ACE inhibitors,
78%; and statins, 89.9%.
3.7. Incidence
The estimated incidence of conﬁrmedACSbased on the number of in-
habitants living in all four counties of the Czech Republic that were
involved in the registry was 2149 cases/million inhabitants/year. The es-
timated incidence of conﬁrmed MI was 1680 cases/million inhabitants/
year, while the estimated incidence of STEMI was 661 cases/million in-
habitants/year. Differences in the estimated incidence of ACS among
the four counties are shown in Fig. 3. A similar estimated incidence of
STEMI was observed in the four counties; however, differences in the
estimated incidence of NSTEMI and UAP were detected.
4. Discussion
Among the patients hospitalized with an initial diagnosis of ACS in
the study area, which covered approximately one-quarter of the popu-
lation of the Czech Republic, 100% were enrolled in our registry. Thus,
our registry provides a real-life picture of the incidence, treatment,
and outcome of ACS in middle-eastern Europe in a country with a
well-established PCI network.
In our registry, ACS was excluded in 30% of admitted patients. ACS
was not conﬁrmed in a similar proportion of patients in the CZECH-1
registry [15]. Based on our analysis, themain initial diagnosis in patients
with subsequently excluded ACS was chest pain with nonspeciﬁc ST-T
changes on the ﬁrst ECG and no relationwas observed in terms of refer-
ring modalities (emergency service/GPs/specialist/patients them-
selves). Only a few registries have included data from unselected
patients admitted under suspicion of ACS. In the GRACE and CANRACE
registries, 14% of the patients did not have a ﬁnal diagnosis of ACSTable 3
Outcome of patients according to the diagnosis at discharge.
STEMI NSTEMI UAP ACS not conﬁrmed
In-hospital mortality 6.1% 6.7% 0.5% 2.1%
30-day mortality 7.3% 8.4% 1.6% 3.5%
In-hospital MACE 7.9% 9.0% 0.5% 2.7%
30-day MACE 9.5% 11.9% 4.9% 4.6%
Fig. 3. Estimated incidence of ACS according the region of the Czech Republic (STEMI —
ST-elevation myocardial infarction, MI — myocardial infarction, ACS — acute coronary
syndrome).
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requested at least one positive biomarker, ECG changes, or a document-
ed history of coronary artery disease. It is thus clear that in real clinical
practice, given the challenge of making an appropriate diagnosis, a
high proportion of patients are admitted with possible ACS for whom
ACS is than not conﬁrmed. A rapid diagnostic evaluation in these pa-
tients is essential because they often receive less evidence-based medi-
cal therapy within 24 h of admission or undergo cardiac procedures
during hospitalization [16].
Most patients with STEMI undergo urgent angiography with prima-
ry PCI. In fact, the Czech Republic is ﬁrst among European countries in
terms of the percentage of patients with STEMI who undergo primary
PCI [17]. Only 21% of the patients with STEMI in this study presented
to a regional hospital; the majority were referred directly to a
cardiocenter by emergencymedical personnel. This shows good organi-
zation of the emergency network in terms of handling patients diag-
nosed with STEMI. On the other hand, 20% of the patients with STEMI
sought medical care more than 12 h after the onset of symptoms.
In patients with NSTE-ACS, we observed differences in the invasive
approaches used between cardiocenters and regional hospitals. Only
half of the patients with NSTE-ACS who were admitted to a regional
hospital underwent coronary angiography during hospitalization.
There are three possible explanations for this. First, about 20% of the
patients underwent coronary angiography electively after hospital
discharge. Second, 12.7% of the patients refused to be transferred from
a regional hospital to a PCI center. Third, according to the physicians
at regional hospitals, the patients with NSTEMI-ACS had several comor-
bidities and were considered unsuitable for transfer to a PCI center.
Those patients whowere hospitalized for NSTE-ACS at a regional hospi-
tal were signiﬁcantly older than the patients admitted to a cardiocenter.
A similar approach for invasivemanagement in patients with NSTE-ACS
admitted to non-PCI centers was seen in the ALERT-CZ registry [18].
Coronary angiography was performed during initial hospitalization or
later in 72.5% of the 4625 patients with non-NSTE-ACS.
Surprisingly, we observed similar in-hospital and 30-day mortality
rates in patients with a ﬁnal diagnosis of STEMI or NSTEMI. The mortal-
ity rate among patients with UAP was low. The higher mortality rate in
the NSTEMI groupwas due to in-hospital mortality in patients admittedwith acute heart failure and after resuscitation (9.9 and 26.3%, respec-
tively) and where the diagnosis of NSTEMI was subsequently made.
The in-hospital and 30-daymortality rates in a subgroup of NSTEMI pa-
tients whowere not admitted after resuscitation or without acute heart
failure on admissionwere 4.1 and 4.7%, respectively. Kaul et al. [19] also
showed that the hospital mortality rate among NSTEMI patients who
presented with heart failure was high (13.5%). Acute heart failure
could be a clinical sign of ongoing ischemia in patients with known cor-
onary artery disease and an indicator of an unfavorable outcome; thus,
these patients may beneﬁt from rapid transfer to a cardiocenter and
early invasive management. The new expert consensus statement of
the Czech Society of Cardiology recommends early stratiﬁcation in pa-
tients with ACS for urgent transfer to cardiocenters and angiography
based on clinical symptoms compatible with ongoingmyocardial ische-
mia and not based on ST-T segment elevation [20].
The estimated incidence of STEMI was similar in all four counties
involved in the registry and is equivalent to the current incidence of
STEMI in Europe and the US [1,13]. Differences were observed in the
estimated incidence of NSTEMI and the estimated incidence of UAP be-
tween the four counties. This can be explained by differences in theﬁnal
diagnosis across 32 centers for patients in a borderline clinical state
(e.g., a ﬁnal diagnosis of UAP or ACS not conﬁrmed in patients admitted
with chest pain but without positive cardiac markers and nonspeciﬁc
ECG changes). The main limitation of this project is the lack of central
monitoring to ensure the same assessment of ﬁnal diagnosis across
the registry. Other limitation is, that the registry collected data of
hospitalized patients only during 2 months from the year and thus,
the incidence of ACS per year has to be regarded as an estimated
incidence. However, when we compared the estimated incidence of
STEMI in our registry with number of primary PCI in the Czech national
registry of cardiovascular intervention (5500 primary PCI in Czech
10 million population in 2010), then the estimated incidence of ACS
has to be very close to the real incidence.
5. Conclusions
This registry presents a real-life picture of the epidemiology and
treatment strategies for unselected patients hospitalized for ACS within
a well-established network of PCI and non-PCI centers. Based on our
data, in daily clinical practice the evaluation of patients hospitalized
with suspected ACS is a major diagnostic challenge (ACS was not
conﬁrmed in 30% of the patients and in 10% of patients with ACS but
without chest pain presented with acute heart failure). Among those
with conﬁrmed ACS, the use of CAG, PCI, CABG, and effective medica-
tions is rational. Unfavorable outcome of patients with ﬁnal diagnosis
of NSTEMI ismainly caused by the high risk population of this subgroup.
Acknowledgments
This registrywas organized by the Third Faculty ofMedicine, Charles
University Prague and was ﬁnancially supported by AstraZeneca Czech
Republic and the South Bohemian Cardiocenter Foundation.
Appendix A. CZECH-2 investigators and centers
Lubomír Ballek, Ondřej Beneš, Pavel Červinka, Jiří Dostál, Antonín
Egert, Jindřich Florián, Pavel Hausdorf, Jana Havelková, Jiří Herman,
Zdeněk Holý, Oldřich Honců, Michal Hondl, Oldřich Honsnejman,
David Horák, David Gerber, Jana Junková, Martina Kalová, Milada
Kladívková, Jitka Kobrlová, Rudolf Koubek Monika Kunová, Bohdan
Lukáč, MarekMika, JanaMikulová, Jiří Malý, ZuzanaNeužilová, Vratislav
Pechman, Ladislav Pešl, Josef Pola, Hana Polívková, Pavla Průšová,
Petr Reichert, Lenka Roblová, Richard Rokyta, Aleš Sedláček, Martin
Straka, Jakub Tocháček, František Toušek, Petr Toušek, Roman Tytl,
Petr Widimský.Regional Hospital, Department of Cardiology, České
Budějovice; Cardiocenter, Hospital Liberec, Liberec; Masaryk Hospital,
208 P. Tousek et al. / International Journal of Cardiology 173 (2014) 204–208Department of Cardiology, Ústi nad Labem; University Hospital Plzeň,
Dept. of Cardiology, Plzeň; Hospital Chomutov, Internal departement;
Hospital Český Krumlov, Internal departement; Hospital Děčín, Internal
departement; Hospital Domažlice, Internal departement; University
Hospital Plzeň, 2nd Internal clinic; University Hospital Plzeň-Bory, In-
ternal departement; Hospital Jablonec nadNisou, Internal departement;
Hospital Jilemnice, Internal departement; Hospital Jindřichův Hradec,
Internal departement; Hospital Litoměřice, Internal departement;
Hospital Most, Internal departement; Mulač Hospital Plzeň, Internal
departement; Hospital Česká Lípa, Internal departement; Hospital
Frýdlant, Internal departement; Hospital Klatovy, Internal departement;
Hospital Stod, Internal departement; Hospital Tanvald, Internal
departement; Hospital Žatec, Internal departement; Hospital Písek,
Internal departement; Hospital Roudnice nad Labem, Internal
departement; Hospital Prachatice, Internal departement; Hospital
Primaved Plzeň, Internal departement; Hospital Rokycany, Internal
departement; Hospital Strakonice, Internal departement; Hospital
Sušice, Internal departement; Hospital Tábor, Internal departement;
Hospital Teplice, Internal departement; Hospital Turnov, Internal
departement.
References
[1] McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in
the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J
Med 2011;124(1):40–7.
[2] Fox KA, Steg PG, Eagle KA, et al. Decline in rates of death and heart failure in acute
coronary syndromes, 1999–2006. JAMA 2007;297(17):1892–900.
[3] Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the in-
cidence and outcomes of acute myocardial infarction. N Engl J Med 2010;362(23):
2155–65.
[4] Puymirat E, Simon T, Steg PG, et al. Association of changes in clinical characteristics
and management with improvement in survival among patients with ST-elevation
myocardial infarction. JAMA 2012;308(10):998–1006.
[5] Wong CX, Sun MT, Lau DH, et al. Nationwide trends in the incidence of acute
myocardial infarction in Australia, 1993–2010. Am J Cardiol 2013;112(2):169–73.
[6] Polonski L, Gasior M, Gierlotka M, et al. Polish Registry of Acute Coronary Syndromes
(PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary
syndromes in Poland. Kardiol Pol 2007;65(8):861–72.
[7] Mohanan PP, Mathew R, Harikrishnan S, et al. Presentation, management, and out-
comes of 25 748 acute coronary syndrome admissions in Kerala, India: results
from the Kerala ACS Registry. Eur Heart J 2013;34(2):121–9.[8] Insam C, Paccaud F, Marques-Vidal P. Trends in hospital discharges, management
and in-hospital mortality from acute myocardial infarction in Switzerland between
1998 and 2008. BMC Public Health 2013;13:270.
[9] Hanssen M, Cottin Y, Khalife K, Hammer L, Goldstein P, Puymirat E. French registry
on acute st-elevation and non st-elevation myocardial infarction 2010. FAST-MI
2010. Heart 2012;98(9):699–705.
[10] Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V. Global and regional
mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic
analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):
2095–128.
[11] Goodman SG, Huang W, Yan AT, et al. The expanded Global Registry of Acute
Coronary Events: baseline characteristics, management practices, and hospital
outcomes of patients with acute coronary syndromes. Am Heart J
2009;158(2):193–201 [e1–5].
[12] http://www.czso.cz/eng/redakce.nsf/i/home.
[13] Steg PG, James SK, Atar D, et al. ESC guidelines for themanagement of acute myocar-
dial infarction in patients presenting with ST-segment elevation: the Task Force on
the management of ST-segment elevation acute myocardial infarction of the
European Society of Cardiology (ESC). Eur Heart J 2012;33(20):2569–619.
[14] Hamm CW, Bassand JP, Agewall S, et al. ESC guidelines for the management of acute
coronary syndromes in patients presenting without persistent ST-segment
elevation: the Task Force for the management of acute coronary syndromes (ACS)
in patients presenting without persistent ST-segment elevation of the European
Society of Cardiology (ESC). Eur Heart J 2011;32(23):2999–3054.
[15] Widimsky P, Zelizko M, Jansky P, Tousek F, Holm F, Aschermann M. The incidence,
treatment strategies and outcomes of acute coronary syndromes in the “reperfusion
network” of different hospital types in the Czech Republic: results of the Czech
evaluation of acute coronary syndromes in hospitalized patients (CZECH) registry.
Int J Cardiol 2007;119(2):212–9.
[16] Bajaj RR, Goodman SG, Yan RT, et al. Treatment and outcomes of patients with
suspected acute coronary syndromes in relation to initial diagnostic impressions
(insights from the Canadian Global Registry of Acute Coronary Events [GRACE]
and Canadian Registry of Acute Coronary Events [CANRACE]). Am J Cardiol
2013;111(2):202–7.
[17] Widimský P, Wijns W, Fajadet J, et al. Reperfusion therapy for ST elevation acute
myocardial infarction in Europe: description of the current situation in 30 countries.
Eur Heart J 2010;31(8):943–57.
[18] Widimsky P, Zvárová J, Monhart Z, Janský P. The use of revascularization strat-
egies in patients with acute coronary syndromes admitted to hospitals without
catheterization facilities: results from the ALERT-CZ registry. Cor Vasa
2013;55(3):e207–11.
[19] Kaul P, Ezekowitz JA, Armstrong PW, et al. Incidence of heart failure and mortality
after acute coronary syndromes. Am Heart J 2013;165(3):379–85 [e2].
[20] Widimsky P, Rokyta R, Stasek J, Belohlavek J, Cervinka P, Kala P. Acute coronary syn-
dromes with ongoing myocardial ischemia (ACS with OMI) versus acute coronary
syndromes without ongoing ischemia (ACS without OMI). The new classiﬁcation
of acute coronary syndromes should replace old classiﬁcation based on ST segment
elevation presence or absence—expert consensus statement of the Czech Society of
Cardiology. Cor Vasa 2013;55(3):e225–7.
